Mersana Therapeutics
MRSN
#8906
Rank
NZ$0.24 B
Marketcap
NZ$48.17
Share price
0.00%
Change (1 day)
89.85%
Change (1 year)

Earnings for Mersana Therapeutics (MRSN)

Earnings in 2025 (TTM): -NZ$0.13 Billion

According to Mersana Therapeutics's latest financial reports the company's current earnings are NZ$33.18 Million. In 2024 the company made an earning of -NZ$0.12 Billion, an increase over its 2023 earnings that were of -NZ$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Mersana Therapeutics from 2016 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.13 Billion5.76%
2024 -NZ$0.12 Billion-59.94%
2023 -NZ$0.29 Billion-15.94%
2022 -NZ$0.34 Billion20.08%
2021 -NZ$0.29 Billion93.16%
2020 -NZ$0.15 Billion212.12%
2019 -NZ$46.73 Million-56.1%
2018 -NZ$0.11 Billion66.02%
2017 -NZ$64.11 Million182.53%
2016 -NZ$22.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.25 Billion 111.22%๐Ÿ‡บ๐Ÿ‡ธ USA